Basics BeiGene, Ltd. American Depositary Shares IPO Date: July 25, 2013 Sector: Healthcare Industry: Biotech Market Cap: $25.76B Activated in VL: True Average Daily Range Avg Daily Range: $3.85 | 1.64% Avg Daily Range (30 D): $3.31 | 1.37% Avg Daily Range (90 D): $3.87 | 1.60% Institutional Daily Volume Avg Daily Volume: .01M Avg Daily Volume (30 D): .31M Avg Daily Volume (90 D): .41M Trade Size Avg Trade Size (Sh.): 40 Avg Trade Size (Sh.) (30 D): 42 Avg Trade Size (Sh.) (90 D): 40 Institutional Trades Total Inst.Trades: 212 Avg Inst. Trade: $6.78M Avg Inst. Trade (30 D): $8.07M Avg Inst. Trade (90 D): $6.87M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $7.18M Avg Closing Trade (30 D): $7.75M Avg Closing Trade (90 D): $7.46M Avg Closing Volume: 29.76K         News May 30, 2025 @ 10:00 AM Zymeworks Announces NMPA Approval of Zanidatamab i... Source: N/A May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Apr 23, 2025 @ 8:05 PM Why Summit Therapeutics Rocketed Double-Digits Tod... Source: Billy Duberstein Apr 17, 2025 @ 10:00 AM Zymeworks to Report First Quarter 2025 Financial R... Source: N/A Apr 3, 2025 @ 3:19 PM BeiGene Discontinues Lung Cancer Drug Study After ... Source: Vandana Singh Financials   TTM N/A N/A Basic EPS $ Diluted EPS $ Revenue $ 1.12B $ $ Gross Profit $ 952.28M $ $ Net Income / Loss $ 1.27M $ $ Operating Income / Loss $ 11.1M $ $ Cost of Revenue $ 165M $ $ Net Cash Flow $ -108.16M $ $ PE Ratio